Common use of Royalty Report Clause in Contracts

Royalty Report. For each calendar quarter for which Licensee has an obligation to make Royalty Payments, such payments shall be accompanied by a report that specifies for such calendar quarter the following information (“Net Sales Report”): (i) total Net Sales of all Licensed Products sold in the Territory; (ii) Net Sales on a country-by-country basis for all Licensed Products sold; (iii) the exchange rate used to convert Net Sales from the currency in which they are earned to United States dollars; and (iv) the total royalties due to Kineta. If Licensee is reporting Net Sales for more than one Licensed Product, the foregoing information shall be reported on a Licensed Product-by-Licensed Product basis.

Royalty Report. For each calendar quarter for which Licensee GNE has an obligation to make Royalty Paymentsroyalty payments, such payments shall be accompanied by a report that specifies for such calendar quarter the following information (“Net Sales Report”): (i) total Net Sales of all Licensed Products sold in the Territory; (ii) Net Sales on a country-by-country basis for all Licensed Products sold; (iii) the exchange rate used to convert Net Sales from the currency in which they are earned to United States dollars; and (iv) the total royalties due to KinetaImmunocore. If Licensee GNE is reporting Net Sales for more than one Licensed Product, the foregoing information shall be reported on a Licensed Product-by-Licensed Product basis. Certain confidential information contained in this document, marked by [***], has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.

Royalty Report. For each calendar quarter for which Licensee GNE has an obligation to make Royalty Paymentsroyalty payments, such payments shall be accompanied by a report that specifies for such calendar quarter the following information (“Net Sales Report”): (ia) total Net Sales of all Licensed Products sold in the Territory; (iib) Net Sales on a country-by-country basis for all Licensed Products sold; (iiic) the exchange rate used to convert Net Sales from the currency in which they are earned to United States dollars; and (ivd) the total royalties due to KinetaImmunocore. If Licensee GNE is reporting Net Sales for more than one Licensed Product, the foregoing information shall be reported on a Licensed Product-by-Licensed Product basis.